Eye Allergy Relief

Manufacturer
Rite Aid Corporation | Bausch & Lomb Incorporated | Loba Feinchemie AG
Effective date
2024-07-22
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 00:15:52

Label at a glance#

ProductEye Allergy Relief
Active ingredientNAPHAZOLINE HYDROCHLORIDE, PHENIRAMINE MALEATE
Label structure9 sections

Indications and uses

temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander

Dosage and administration

Adults and children 6 years of age and older: Instill 1 or 2 drops in the affected eye(s) up to 4 times daily. Children under 6 years: ask a doctor

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Naphazoline HCl (0.02675%)

Pheniramine maleate (0.315%)

Purpose

OTC - PURPOSE SECTION

Redness reliever

Antihistamine

Uses

INDICATIONS & USAGE SECTION

temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • if you are sensitive to any ingredient in this product
  • if solution changes color or becomes cloudy

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • heart disease
  • high blood pressure
  • trouble urinating due to an enlarged prostate gland
  • narrow angle glaucoma

When using this product

OTC - WHEN USING SECTION

  • overuse may cause more eye redness
  • pupils may become enlarged temporarily
  • do not touch tip of container to any surface to avoid contamination
  • you may feel a brief tingling after putting drops in eye
  • replace cap after use
  • remove contact lenses before using

Stop use and ask a doctor if you experience

OTC - STOP USE SECTION

  • eye pain
  • changes in vision
  • redness or irritation of the eye that worsens or lasts more than 72 hours

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away. Accidental oral ingestion in infants and children may lead to coma and marked reduction in body temperature.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Adults and children 6 years of age and older:Instill 1 or 2 drops in the affected eye(s) up to 4 times daily.
  • Children under 6 years:ask a doctor

Other information

SPL UNCLASSIFIED SECTION

  • store at 20-25° C (68-77° F)
  • this package is child-resistant
  • protect from light
  • use before expiration date marked on the carton or bottle

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzalkonium chloride, boric acid, edetate disodium, hypromellose, purified water, sodium borate, sodium chloride. Hydrochloric acid may be used to adjust pH.

Questions or comments?

OTC - QUESTIONS SECTION

{phone icon} call: 1-866-767-8975

Package/Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

carton
carton

TWIN PACK

Compare to Opcon-A®
active ingredients*

NDC 11822-0552-2

EYE ALLERGY

RELIEF DROPS

pheniramine maleate 0.315% and

naphazoline hydrochloride 0.02675%

ophthalmic solution

ANTIHISTAMINE AND

REDNESS RELIEVER

STERILE

2 ×15 mL BOTTLES

(0.5 FL OZ EACH)

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1043704naphazoline HCl 0.02675 % / pheniramine maleate 0.315 % Ophthalmic SolutionPSN5
1043704naphazoline hydrochloride 0.27 MG/ML / pheniramine maleate 3.15 MG/ML Ophthalmic SolutionSCD5
1043704naphazoline HCl 0.02675 % / pheniramine maleate 0.315 % Ophthalmic SolutionSY5
1043704naphazoline HCl 0.027 % / pheniramine maleate 0.315 % Ophthalmic SolutionSY5

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e18001c8-33ae-5f66-9cdc-a39724bd4573Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
11822-0552-12021-06-09C16284748780-1ba0f9c33-413d-a910-e053-dadaa90a0b85Drug Facts
11822-0552-22021-06-09C16284748780-1ba0f9c33-413d-a910-e053-dadaa90a0b85Drug Facts
11822-0552-12021-01-29C16284748780-1ba0f9c33-413d-a910-e053-dadaa90a0b85Drug Facts
11822-0552-22021-01-29C16284748780-1ba0f9c33-413d-a910-e053-dadaa90a0b85Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11822-0552-1Eye Allergy Relief1 in 1 CARTONSOLUTION/ DROPS15
11822-0552-1Eye Allergy Relief15 mL in 1 BOTTLE, DROPPERSOLUTION/ DROPS155
11822-0552-2Eye Allergy Relief15 mL in 1 BOTTLE, DROPPERSOLUTION/ DROPS155
11822-0552-2Eye Allergy Relief2 in 1 CARTONSOLUTION/ DROPS25

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11822-0552EYE ALLERGY RELIEF (PHENIRAMINE MALEATE AND NAPHAZOLINE HYDROCHLORIDE) SOLUTION/ DROPS [RITE AID CORPORATION]5Legacy NDC, 4 package rows20240724_6043040e-3206-40dd-aa87-940b1a84a496.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
NAPHAZOLINE HYDROCHLORIDEACTIVE INGREDIENTMZ1131787D1
PHENIRAMINE MALEATEACTIVE INGREDIENTNYW905655B1
NAPHAZOLINEACTIVE MOIETYH231GF11BV1
PHENIRAMINEACTIVE MOIETY134FM9ZZ6M1
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W71
BORIC ACIDINACTIVE INGREDIENTR57ZHV85D41
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86K1
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CB1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WO1
SODIUM BORATEINACTIVE INGREDIENT91MBZ8H3QO1
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8X1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11822-055211822-0552-1, 11822-0552-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 27 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
BORIC ACIDBORIC ACIDR57ZHV85D4SOLUTION/ DROPS / OPHTHALMIC48 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION/ DROPS / OPHTHALMIC0.13 %w/vExact identifier — unii+route+dosage form
3 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSUSPENSION/ DROPS / OPHTHALMIC3 mgExact identifier — unii+route
9 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBSOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
3 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSOLUTION / OPHTHALMIC0.5 %w/vExact identifier — unii+route
9 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBSOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
3 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION/ DROPS / OPHTHALMIC55 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSUSPENSION / OPHTHALMIC0.5 %w/wExact identifier — unii+route
9 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION/ DROPS / OPHTHALMIC55 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSUSPENSION / OPHTHALMIC0.5 %w/wExact identifier — unii+route
9 equally ranked IID candidates
SODIUM BORATESODIUM BORATE91MBZ8H3QOSOLUTION/ DROPS / OPHTHALMIC1.1 %w/vExact identifier — unii+route+dosage form
3 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / OPHTHALMIC1 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION/ DROPS / OPHTHALMIC0.13 %w/vExact identifier — unii+route+dosage form
3 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION/ DROPS / OPHTHALMIC55 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
BORIC ACIDBORIC ACIDR57ZHV85D4SOLUTION/ DROPS / OPHTHALMIC48 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / OPHTHALMIC1 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
BORIC ACIDBORIC ACIDR57ZHV85D4SOLUTION/ DROPS / OPHTHALMIC48 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSOLUTION / OPHTHALMIC0.5 %w/vExact identifier — unii+route
9 equally ranked IID candidates
SODIUM BORATESODIUM BORATE91MBZ8H3QOSOLUTION/ DROPS / OPHTHALMIC1.1 %w/vExact identifier — unii+route+dosage form
3 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION/ DROPS / OPHTHALMIC0.13 %w/vExact identifier — unii+route+dosage form
3 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBSOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
3 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSUSPENSION/ DROPS / OPHTHALMIC3 mgExact identifier — unii+route
9 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / OPHTHALMIC1 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSUSPENSION / OPHTHALMIC0.5 %w/wExact identifier — unii+route
9 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSOLUTION / OPHTHALMIC0.5 %w/vExact identifier — unii+route
9 equally ranked IID candidates
SODIUM BORATESODIUM BORATE91MBZ8H3QOSOLUTION/ DROPS / OPHTHALMIC1.1 %w/vExact identifier — unii+route+dosage form
3 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSUSPENSION/ DROPS / OPHTHALMIC3 mgExact identifier — unii+route
9 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020065-001OPCON-ANAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-0884e616aacf4f…
2026-08-18 06:07:402026-07N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-0831067a03dcf5…
2025-08-23 18:47 UTC2025-08N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-086a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-0803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-082680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-085bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-0879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-081e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-088072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-085c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-085d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-084b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-0874a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-0887673890dc5c…
2021-03-12 10:30 UTC2021-03N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-085aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-088869cabd3fbd…
2020-11-12 02:37 UTC2020-11N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08c0c555d07b60…
2019-12-14 00:12 UTC2019-12N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-083f01610625f2…
2019-09-15 20:21 UTC2019-09N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08b00525d2431f…
2019-07-19 19:46 UTC2019-07N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-086a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-081c564ffb4f44…
2023-12-20 04:57 UTC2023-12N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-089b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-083f0d92c62455…
2023-05-13 08:27 UTC2023-05N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08053a50430f4f…
2023-01-26 05:58 UTC2023-01N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-083bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-083a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N020065-001OPCON-A0.02675%;0.315%SOLUTION/DROPS / OPHTHALMICRLD, RS1994-06-08f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Eye Allergy ReliefPHENIRAMINE MALEATE AND NAPHAZOLINE HYDROCHLORIDERite Aid Corporation6043040e-3206-40dd-aa87-940b1a84a4962024-07-22WarningsExact identifier
ndc (package): 11822-0552-2
ndc (package): 11822-0552-1
ndc (product): 11822-0552
ndc11 (package): 11822055201
ndc11 (package): 11822055202
spl id: 1ddd20f0-11d5-dbe0-e063-6394a90ada1f
spl set id: 6043040e-3206-40dd-aa87-940b1a84a496

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.